|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Income/(loss) before tax | |||||
| Depreciation, amortisation and net impairment losses | |||||
| Exploration expenditures written off | |||||
| Depreciation, amortisation and net impairments, including exploration write-offs | |||||
| (Gains)/losses on foreign currency transactions and balances | |||||
| (Gains)/losses on sale of assets and businesses | |||||
| (Increase)/decrease in other items related to operating activities | |||||
| (Increase)/decrease in net derivative financial instruments | |||||
| Cash collaterals for commodity derivative transactions | |||||
| Interest received | |||||
| Interest paid | |||||
| Cash flows provided by operating activities before taxes paid and working capital items | |||||
| Taxes paid | |||||
| (Increase)/decrease in working capital | |||||
| Cash flows provided by operating activities | |||||
| Cash used in business combinations | |||||
| Capital expenditures and investments | |||||
| (Increase)/decrease in financial investments | |||||
| (Increase)/decrease in derivative financial instruments | |||||
| (Increase)/decrease in other interest-bearing items | |||||
| Proceeds from sale of assets and businesses | |||||
| Cash flows provided by/(used in) investing activities | |||||
| New finance debt | |||||
| Repayment of finance debt | |||||
| Repayment of lease liabilities | |||||
| Dividends paid | |||||
| Share buy-back | |||||
| Net current finance debt and other financing activities | |||||
| Cash flows provided by/(used in) financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Foreign currency translation effects | |||||
| Cash and cash equivalents at the beginning of the period (net of overdraft) | |||||
| Cash and cash equivalents at the end of the period (net of overdraft) | |||||
| Bank overdrafts |
Loading...
